The ability of CYP enzymes to activate prodrugs within cancer cells, the impact of genetic polymorphisms on CYP enzyme activity, and the potential to reduce toxicity while maintaining therapeutic efficacy highlight the significance of CYP enzymes in GDEPT. Here, PPIG is linked to cancer.